LKB1 drives stasis and C/EBP-mediated reprogramming to an alveolar type II fate in lung cancer

Bibliographic Details
Title: LKB1 drives stasis and C/EBP-mediated reprogramming to an alveolar type II fate in lung cancer
Authors: Christopher W. Murray, Jennifer J. Brady, Mingqi Han, Hongchen Cai, Min K. Tsai, Sarah E. Pierce, Ran Cheng, Janos Demeter, David M. Feldser, Peter K. Jackson, David B. Shackelford, Monte M. Winslow
Source: Nature Communications, Vol 13, Iss 1, Pp 1-19 (2022)
Publisher Information: Nature Portfolio, 2022.
Publication Year: 2022
Collection: LCC:Science
Subject Terms: Science
More Details: LKB1 tumour suppressor gene is frequently mutated in lung adenocarcinoma. Here the authors show that in genetically engineered mouse models of lung cancer Lkb1 restoration induces growth arrest and drives neoplastic cells toward a more differentiated and less proliferative alveolar type II cell-like state via C/EBP-mediated reprogramming.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2041-1723
Relation: https://doaj.org/toc/2041-1723
DOI: 10.1038/s41467-022-28619-8
Access URL: https://doaj.org/article/fac054136b674b659d92c440e9e9e2b2
Accession Number: edsdoj.fac054136b674b659d92c440e9e9e2b2
Database: Directory of Open Access Journals
More Details
ISSN:20411723
DOI:10.1038/s41467-022-28619-8
Published in:Nature Communications
Language:English